EZH2 and prostate cancer: Chromatin immune-precipitation and parallel sequencing showed that TMPRSS2–ERG was involved in the development of prostate cancer through disruption of lineage-specific differentiation and potentiation of the EZH2-mediated de-differentiation program [55].